Callos Andrew sold CYTK
March 17, 2026 · Form 4 insider transaction
Callos Andrew sold 2,916 shares of Cytokinetics, Incorporated at $62.15 per share, a transaction worth $181.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,916
Price
$62.15
Total value
$181.2K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 18, 2026
Shares owned after71,573
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting.